In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen
- 1 July 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 166 (2) , 251-260
- https://doi.org/10.1016/0014-2999(89)90066-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Neurochemical and behavioural profile of Lu 17‐133, (±)‐trans‐4‐[3‐(3,4‐dichlorophenyl)‐indan‐1‐yl]‐1‐piperazineethanol, an inhibitor of the uptake of dopamine and noradrenalineDrug Development Research, 1988
- Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systemsLife Sciences, 1987
- 3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptakeJournal of Medicinal Chemistry, 1985
- Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatmentsBrain Research Reviews, 1983
- Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindansJournal of Medicinal Chemistry, 1983
- NomifensineDrugs, 1979
- The central stimulatory action of inhibitors of the dopamine uptakeLife Sciences, 1979
- Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in ratsJournal of Pharmacy and Pharmacology, 1977
- Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depressionPsychopharmacology, 1977
- Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatumJournal of Pharmacy and Pharmacology, 1974